Cancer Research · 2008 · 731 citations · 28 references
Life SciencesCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesRedox SignalingSignal Transduction In CancerCellular Oxidative Stress ResponseCellular Response To Oxidative StressExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingMalignant ProgressionOxidative Stress In CancerOxidative Stress In Signal TransductionRedox Signaling In Cell Proliferation
Reactive oxygen species (ROS) and the coupled oxidative stress have been associated with tumor formation. Several studies suggested that ROS can act as secondary messengers and control various signaling cascades. In the present studies, we characterized the oxidative stress status in three different prostate cancer cells (PC3, DU145, and LNCaP) exhibiting various degree of aggressiveness and normal prostate cells in culture (WPMY1, RWPE1, and primary cultures of normal epithelial cells). We observed increased ROS generation in cancer cells compared with normal cells, and that extramitochondrial source of ROS generator, NAD(P)H oxidase (Nox) systems, are associated with the ROS generation and are critical for the malignant phenotype of prostate cancer cells. Moreover, diphenyliodonium, a specific Nox inhibitor, blocked proliferation, modulated the activity of growth signaling cascades extracellular signal-regulated kinase (ERK)1/ERK2 and p38 mitogen-activated protein kinase as well as AKT protein kinase B, and caused cyclin B-dependent G(2)-M cell cycle arrest. We also observed higher degrees of ROS generation in the PC3 cells than DU145 and LNCaP, and that ROS generation is critical for migratory/invasiveness phenotypes. Furthermore, blocking of the ROS production rather than ROS neutralization resulted in decreased matrix metalloproteinase 9 activity as well as loss of mitochondrial potential, plausible reasons for decreased cell invasion and increased cell death. Taken together, these studies show, for the first time, the essential role of ROS production by extramitochondrial source in prostate cancer and suggest that therapies aimed at reducing ROS production might offer effective means of combating prostate cancer in particular, and perhaps other malignancies in general.
28
Clonogenic assay of cells in vitro
Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations
Production of large amounts of hydrogen peroxide by human tumor cells.
Ted P. Szatrowski, Carl Nathan · PubMed · 1991 · 2.5K citations
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Amy R. Nelson, Barbara Fingleton, Mace L. Rothenberg et al. · Journal of Clinical Oncology · 2000 · 1.6K citations
Medicine, Cancer Biology, Oncology +14
Cell transformation by the superoxide-generating oxidase Mox1
Young‐Ah Suh, Rebecca S. Arnold, Bernard Lassègue et al. · Nature · 1999 · 1.5K citations
Tianzheng Yu, James L. Robotham, Yisang Yoon · Proceedings of the National Academy of Sciences · 2006 · 1.2K citations · Full text